/Investor DB

I2BF Global Ventures — 2021 Investments

7 investments dated 2021 · listed companies and verified rows first · show all

Agathosagathos.io𝕏Aug 2021

CareInsights (formerly Agathos) is a mobile-first platform that delivers personalized peer-comparison insights on clinical metrics directly to physicians via text to drive improvements in care quality and reduce costs.

Digital HealthEnterprise SoftwareHealthtechBoulder, US

Andrew Trees(Executive Officer, Director)STEVE WAYE(Executive Officer, Director)

BoardMARK BAKKEN(Director)inELISE MILLER HOFFMAN(Director)in

Co-investorsBetter Ventures Central LlcNarrow Gauge VenturesNewfund CapitalStartXCultivation CapitalHealthX Ventures

Bolsterbolsterbuilt.comin𝕏Seed · Oct 2021 · $8.4M

Bolster provides construction management software for residential construction, focusing on estimation and digital workflows to modernize how projects are bought, sold, and managed.

Construction TechFintechMarketplacesPropTechSaaSCalgary, CA

Mike Bignold(Founder)inAbhishek Dubey(Founder)Shashi Prakash(Founder)Dave VassLewis Cowie(COO)Jena Rhydderch(Human Resources)

Co-investorsCathexis VenturesFUSESoma CapitalTakeoff CapitalY CombinatorCERVIN VENTURES+13 more

CakeHealthcakehealth.com𝕏Oct 2021 · $1.5M

Cakehealth.com is a health information and product-review website presented as merged with Dualdiagnosis.org, covering topics such as CBD, medical trends, mental and physical health, and supplement product tests.

ConsumerHealthtechMedia & EntertainmentWellness & Fitness

Andy BrettRebecca Woodcockin

Co-investors500 GlobalConnecticut InnovationsLaunch Capital

Ctogramctogram.kzSeed · Nov 2021 · $700K

Co-investorsQuest Ventures

Peekpeek.usinNov 2021 · $80M

Peek provides a leasing automation platform for multifamily property managers that uses 3D unit tours, conversational AI, and content automation to reduce vacancy periods and accelerate lease signings.

AI & Machine LearningPropTechSaaSSan Francisco, US

Oskar Bruening(Founder)in

Co-investorsCathay InnovationManta Ray VenturesModerne VenturesMoneta VenturesCathay CapitalGoldman Sachs+1 more

PostErapostera.aiin𝕏Series A · Dec 2021

Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US

Aaron Morris(Founder)inAlpha Lee(Chief Scientific Officer)inMatthew Robinson(Founder)inMatt Robinson(Founder)Milan Cvitkovic(ML Researcher)Ruby Pai(ML Researcher)

Co-investorsBreyer CapitalHOF CapitalLifeforce CapitalMetaplanetPioneerY Combinator+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

UvU Shuttle

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.